FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1363921000168105: insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL injection, 1 x 3 mL pen device (medicinal product pack)


Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4151891000168113 insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL injection, 1 x 3 mL pen device (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4151901000168112 insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device en Synonym Active Case sensitive Australian Medicines Terminology module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device Is a lixisenatide 10 microgram / 0.2 mL injection, 1 x 3 mL pen device (medicinal product pack) true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device Is a insulin glargine 100 units/mL injection, 3 mL pen device true Inferred relationship Some
insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device has MPUU insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Soliqua 100/50 injection, 3 mL pen device Is a True insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device Inferred relationship Some

Reference Sets

List of Medicines for Brand Consideration reference set

Medicinal product pack reference set

Back to Start